Daiichi Sankyo Co., Ltd. Stock price Deutsche Boerse AG

Equities

D4S

JP3475350009

Pharmaceuticals

Market Closed - Deutsche Boerse AG 10:17:47 2024-03-28 am EDT 5-day change 1st Jan Change
29.79 EUR -0.17% Intraday chart for Daiichi Sankyo Co., Ltd. +1.64% +22.14%

Financials

Sales 2024 * 1,581B 10.44B 9.69B Sales 2025 * 1,758B 11.62B 10.78B Capitalization 9,200B 60.77B 56.4B
Net income 2024 * 168B 1.11B 1.03B Net income 2025 * 190B 1.26B 1.17B EV / Sales 2024 * 5.47 x
Net cash position 2024 * 556B 3.67B 3.41B Net cash position 2025 * 595B 3.93B 3.65B EV / Sales 2025 * 4.89 x
P/E ratio 2024 *
54.8 x
P/E ratio 2025 *
48.4 x
Employees 17,435
Yield 2024 *
0.94%
Yield 2025 *
1.08%
Free-Float 97.04%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Daiichi Sankyo Co., Ltd.

1 day-0.17%
1 week+1.64%
Current month-1.39%
1 month-2.39%
3 months+22.24%
6 months+13.01%
Current year+22.14%
More quotes
1 week
28.89
Extreme 28.89
29.84
1 month
28.25
Extreme 28.25
30.52
Current year
24.46
Extreme 24.46
33.13
1 year
22.35
Extreme 22.35
34.48
3 years
15.05
Extreme 15.05
34.80
5 years
12.86
Extreme 12.8567
34.80
10 years
3.72
Extreme 3.717
34.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 69 07-03-31
Director of Finance/CFO 61 17-03-31
Chief Tech/Sci/R&D Officer - 21-03-31
Members of the board TitleAgeSince
Chairman 75 14-05-31
Director/Board Member 66 19-05-31
Director/Board Member 75 19-05-31
More insiders
Date Price Change Volume
24-03-28 29.79 -0.17% 50
24-03-27 29.84 +2.83% 0
24-03-26 29.02 +0.17% 155
24-03-25 28.97 -4.70% 190
24-03-22 30.4 +3.72% 1,506

Delayed Quote Deutsche Boerse AG, March 28, 2024 at 10:17 am EDT

More quotes
Daiichi Sankyo Company specializes in developing, manufacturing and marketing pharmaceutical products. Net sales break down by activity as follows: - sale of medicines (99.8%): prescription medicines (92.8% of net sales) and OTC medicines (7.2%) primarily for the treatment of thrombotic disorders, tumors, diabetes and rheumatoid arthritis; - other (0.2%): primarily real estate activities. Net sales are distributed geographically as follows: Japan (64.1%), North America (17.2%), Europe (9.7%) and other (9%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
4,798 JPY
Average target price
5,620 JPY
Spread / Average Target
+17.13%
Consensus
  1. Stock
  2. Equities
  3. Stock Daiichi Sankyo Co., Ltd.
  4. Stock Daiichi Sankyo Co., Ltd. - Deutsche Boerse AG